← Back to Search

Behavioral Intervention

Violence Prevention for Women with Substance Use Disorders

N/A

Recruiting

Led By Heidi Zinzow, Ph.D.

Research Sponsored by Clemson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 or higher

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up participants complete this measure at baseline, post intervention (2 weeks), 1 month follow-up (6 weeks), and 3 month follow-up (18 weeks).

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a violence prevention program for women in substance use treatment, delivered by peer support specialists. The program includes screening for PTSD, providing resources, and two sessions on preventing violence.

Who is the study for?

This trial is for women over 18 who identify as female and are currently in substance use treatment. They must be able to participate in educational sessions, meaning they can't have acute conditions like active psychosis or suicidality, and they need to speak English.

What is being tested?

The study tests a violence prevention program delivered by peer support specialists. It includes PTSD screening, resource referral, and two sessions on preventing interpersonal violence. Participants will complete surveys before the program starts, after it ends, one month later, and three months later.

What are the potential side effects?

Since this intervention involves education and support rather than medication or medical procedures, typical side effects associated with drugs are not expected. However, discussing trauma could potentially cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ participants complete this measure at baseline, post intervention (2 weeks), 1 month follow-up (6 weeks), and 3 month follow-up (18 weeks).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~participants complete this measure at baseline, post intervention (2 weeks), 1 month follow-up (6 weeks), and 3 month follow-up (18 weeks).

This trial's timeline: 3 weeks for screening, Varies for treatment, and participants complete this measure at baseline, post intervention (2 weeks), 1 month follow-up (6 weeks), and 3 month follow-up (18 weeks). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

ARC3 Consent Scale

Attitudes Towards Dating Violence

Barriers to Resistance

+4 more

Secondary study objectives

CAGE-AID (Substance Use)

PC-PTSD-5

PHQ-2 (Depression)

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Screening/Referral and PreventionExperimental Treatment1 Intervention

Participants will receive a brief PTSD screening, warm handoff to trauma-focused resources if screening positive, and two session peer support specialist-delivered educational program on interpersonal violence prevention.

0 / 1Eligibility criteria met